PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues

European Journal of Endocrinology

Volumn 151, Issue 3, 2004, Pages 367-374

  Lacroix, Ludovic ^a   Mian, Caterina ^a   Barrier, Thierry ^a   Talbot, Monique ^a   Caillou, Bernard ^a   Schlumberger, Martin ^a   Bidart, Jean Michel ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR PAX8;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLICULAR CARCINOMA; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THYROID CANCER; THYROID TUMOR; TUMOR CLASSIFICATION;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; CARCINOMA, PAPILLARY; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NUCLEAR PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; POLYMORPHISM, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID NEOPLASMS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 4744343050     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1510367     Document Type: Article

References (32)

1. Hedinger C, Williams ED & Sobin LH. Histological typing of thyroid tumors. In International Histological Classification of Tumors. 2nd edition. vol. 11. Berlin: Springer-Verlag, 1998.
2. Fagin FA. Molecular genetics of tumors of thyroid follicular cells. In The Thyroid, 8th edition, pp 886-898. Eds LE Braverman & RD Utiger. Philadelphia: Lippincott, Williams and Wilkins, 2000.
3. Pierotti MA. Chromosomal rearrangements in thyroid carcinomas: a recombination or death dilemma. Cancer Letters 2001 166 1-7.
4. Bongarzone I, Butti MG, Coronelli S, Borrello MG, Santoro M, Mondellini P, Pilotti S, Fusco A, Della Porta G & Pierotti MA. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Research 1994 54 2979-2985.
5. Roque L, Rodrigues R, Pinto A, Moura-Nunes V & Soares J. Chromosome imbalances in thyroid follicular neoplasms: a comparison between follicular adenomas and carcinomas. Genes Chromosomes and Cancer 2003 36 292-302.
6. Lui W, Kytölä S, Anfalk L, Larsson C & Farnebo L. Balanced translocation (3:7) (p25;q34): another mechanism of tumorigenesis in follicular thyroid carcinomas? Cancer Genetics and Cytogenetics 2000 119 109-112.
7. Kroll TG. Sarraf P, Pecciarini L, Chen C, Mueller E, Spiegelman BM & Fletcher J. PAXS-PPARγ1 fusion oncogene in human thyroid carcinoma. Science 2000 289 1357-1360.
8. Desvergne B & Wahli W. Peroxisome proliferator-actived receptors: nuclear control of metabolism. Endocrine Review 1999 20 649-688.
9. Rosen ED & Spiegelman BM. PPAR gamma: a nuclear regulator of metabolism, differentiation, and cell growth. Journal of Biological Chemistry 2001 276 37731-37734.
10. Koeffler HP. Peroxisome proliferator-activated receptor gamma and cancers. Clinical Cancer Research 2003 9 1-9.
11. Ohta K, Endo T, Haraguchi K, Hershman JM & Onaya T. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells. Journal of Clinical Endocrinology and Metabolism 2001 86 2170-2177.
12. Martelli ML, Iuliano R, Le Pera I, Sama I, Monaco C, Cammarota S, Kroll T, Chiariotti L, Santoro M & Fusco A. Inhibitory effects of peroxisome proliferator-activated receptor gamma on thyroid carcinoma cell growth. Journal of Clinical Endocrinology and Metabolism 2002 87 4728-4735.
13. Chung SH, Onoda N. Ishikawa T, Ogisawa K, Takenaka C, Yano Y, Hato F & Hirakawa K. Peroxisome proliferator-activated receptor gamma activation induces cell cycle arrest via the p53-independent pathway in human anaplastic thyroid cancer cells. Japanese Journal of Cancer Research 2002 93 1358-1365.
14. Ikezoe T, Miller CW, Kawano S, Heaney A, Williamson EA, Hisatake J, Green E, Hofmann W, Taguchi H & Koeffler HP. Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies. Cancer Research 2001 61 5307-5310.
15. Smith WM, Zhou XP. Kurose K, Gao X, Latif F, Kroll T, Sugano K, Cannistra SA, Clinton SK, Maher ER, Prior TW & Eng C. Opposite association of two PPARgamma variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and under-representation of P12A in renal cell carcinoma cases. Human Genetics 2001 109 146-151.
16. Yoshimura R, Matsuyama M, Segawa Y, Hase T, Mitsuhashi M, Tsuchida K, Wada S, Kawahito Y. Sano H & Nakatani T. Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists. International Journal of Cancer 2003 104 597-602.
17. Damante G, Tell G & Di Lauro, R. A unique combination of transcription factors controls differentiation of thyroid cells. Progress in Nucleic Acid Research and Molecular Biology 2000 66 307- 356.
18. Fabbro D, Di Loreto C, Beltrami CA, Belfiore A, Di Lauro R & Damante G. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Research 1994 54 4744-4749.
19. Nikiforova MN. Biddinger PW, Caudill CM, Kroll TG & Nikiforov YE. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. American Journal of Surgical Pathology 2002 26 1016-1023.
20. Marques AR, Espadinha C, Catarino AL, Moniz S, Pereira T, Sobrinho LG & Leite V. Expression of PAXS-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. Journal of Clinical Endocrinology and Metabolism 2002 87 3947-3952.
21. Cheung L, Messina M, Gill A, Clarkson A, Learoyd D, Delbridge L. Wentworth J, Philips J, Clifton-Bligh R & Robinson BG. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. Journal of Clinical Endocrinology and Metabolism 2003 88 354-357.
22. French CA, Alexander EK, Cibas ES, Nose V, Laguette J, Faquin W, Garber J, Moore F Jr, Fletcher JA, Larsen PR & Kroll TG. Genetic and biological subgroups of low-stage follicular thyroid cancer. American Journal of Pathology 2003 162 1053-1060.
23. Nikiforova MN, Lynch RA, Biddinger PW. Alexander EK, Dorn GW 2nd, Tallini G, Kroll TG & Nikiforov YE. RAS point mutations and PAXS-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. Journal of Clinical Endocrinology and Metabolism 2003 88 2318-2326.
24. Aldred MA, Morrison C, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang S & Eng G. Peroxisome proliferator-activated receptor gamma is frequently downregulated in a diversity of sporadic nonmedullary thyroid carcinomas. Oncogene 2003 22 3412-3416.
25. Zhu Z, Gandhi M, Nikiforova MN, Fischer AH & Nikiforov YE. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. American Journal of Clinical Pathology 2003 120 71-77.
26. Gustafson KS, LiVolsi VA. Furth EE, Pasha TL, Putt ME & Baloch ZW. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies. American Journal of Clinical Pathology 2003 120 175-181.
27. Dwight T, Thoppe SR, Foukakis T, Lui WO, Wallin G, Hoog A, Frisk T, Larsson C & Zedenius J. Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors. Journal of Clinical Endocrinology and Metabolism 2003 88 4440-4445.
28. American Joint Committee on Cancer, Thyroid. In AJCC Cancer Staging Handbook, 6th edition, ch. 8, pp 89-98. New York: Springer, 2002.
29. - symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. Journal of Clinical Endocrinology and Metabolism 1999 84 3228-3234.
30. Bieche I, Franc B, Vidaud D, Vidaud M & Lidereau R. Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction. Thyroid 2001 11 147-152.
31. Valve R, Sivenius K, Miettinen R, Pihlajamaki J, Rissanen A, Deeb SS, Auwerx J, Uusitupa M & Laakso M. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women. Journal of Clinical Endocrinology and Metabolism 1999 84 3708-3712.
32. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J & Shuldiner AR. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochemical and Biophysical Research Communications 1997 241 270-274.